Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Allogeneic bone marrow derived mesenchymal cells expanded ex vivo in synthetic media

EU orphan designation number: EU/3/13/1129   
Active ingredient: Allogeneic bone marrow derived mesenchymal cells expanded ex vivo in synthetic media
Indication: Treatment of graft-versus-host disease
Sponsor: Cell2B Advanced Therapeutics, SA
Biocant Park, Parque Tecnológico de Cantanhede, Nucleo 4, Lote 4A, 3060-197 Cantanhede, Portugal

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Centralised Orphan - Designation EMA/OD/197/12 (2013)3665 of 07/06/2013
08/10/2013 Corrigendum (2013)6707 of 04/10/2013